Literature DB >> 17185876

Seroprevalence of leptospirosis in high risk groups in Calicut, North Kerala, India.

R N Swapna1, U Tuteja, L Nair, J Sudarsana.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 17185876     DOI: 10.4103/0255-0857.29418

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


× No keyword cloud information.
  5 in total

1.  A case-control study of epidemiological factors associated with leptospirosis in South Gujarat region.

Authors:  K T Desai; F Patel; P B Patel; S Nayak; N B Patel; R K Bansal
Journal:  J Postgrad Med       Date:  2016 Oct-Dec       Impact factor: 1.476

2.  Seroprevalence of Leptospirosis among High-Risk Individuals in Morocco.

Authors:  Mohamed El Azhari; Mathieu Picardeau; Imad Cherkaoui; Mohamed Anouar Sadat; Houda Moumni; Kamal Marhoum El Filali; Hassan Ghazal; Abderrahmane Maaroufi; Salsabil Hamdi; Naima El Mdaghri; Pascal Bourhy
Journal:  Interdiscip Perspect Infect Dis       Date:  2020-05-20

3.  Decreasing trend of seroprevalence of leptospirosis at All India Institute of Medical Sciences New Delhi: 2014-2018.

Authors:  Sonu Kumari Agrawal; Rama Chaudhry; Nitin Gupta; Nazneen Arif; Tej Bhadur
Journal:  J Family Med Prim Care       Date:  2018 Nov-Dec

4.  Increasing trends of leptospirosis in northern India: a clinico-epidemiological study.

Authors:  Sunil Sethi; Navneet Sharma; Nandita Kakkar; Juhi Taneja; Shiv Sekhar Chatterjee; Surinder Singh Banga; Meera Sharma
Journal:  PLoS Negl Trop Dis       Date:  2010-01-12

5.  Diagnostic efficacy of lsa63 antigen for human leptospirosis.

Authors:  Safar Ali Alizadeh; Seyyed Saeed Eshraghi; Mohammad Reza Pourmand; Taghi Naserpour; Gholamreza Abdollahpour; Abbas Rahimiforoshani; Reza Najafipour
Journal:  Iran Red Crescent Med J       Date:  2014-03-05       Impact factor: 0.611

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.